| REVIEW ARTICLE |
|
| Year : 2019 | Volume
: 18
| Issue : 1 | Page : 8-12 |
|
|
A tribute to Dr. Saul Hertz: The discovery of the medical uses of radioiodine
Barbara Hertz
Curator, Dr. Saul Hertz Archives and Saul Hertz MD.com, USA
Correspondence Address:
Barbara Hertz
Dr. Saul Hertz Archives and Saul Hertz MD.com, 6 Buckthorne Lane, Greenwich - 06830, CT
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/wjnm.WJNM_107_18
|
|
|
Dr. Saul Hertz was Director of The Massachusetts General Hospital's Thyroid Unit, when he heard about the development of artificial radioactivity. He conceived and brought from bench to bedside the successful use of radioiodine (RAI) to diagnose and treat thyroid diseases. Thus was born the science of theragnostics used today for neuroendorine tumors and prostate cancer. Dr. Hertz's work set the foundation of targeted precision medicine. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 478 
